Tango Therapeutics Inc

NASDAQ:TNGX   3:59:59 PM EDT
7.54
+0.32 (+4.43%)
Earnings Announcements

Tango Therapeutics Reports Third Quarter 2022 Results

Published: 11/10/2022 12:47 GMT
Tango Therapeutics Inc (TNGX) - Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Highlights.
Qtrly Loss per Share $0.33.
Q3 Earnings per Share View $-0.32 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.32 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $6.66 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.